P096. Deep Hypothermic Circulatory Arrest in the Repair of Descending and Thoracoabdominal Aortic Aneurysms: Is It Safe?
Presented During: POD Abstracts (Available for viewing in the exhibit hall for the duration of the meeting)
Thomas Jefferson University Hospital
philadelphia, PA
United States - Contact Me
Joshua Chen is a 3rd year medical student at Sidney Kimmel Medical College interested in a career in academic cardiothoracic surgery.
Thursday, April 25, 2024: 5:38 PM - 7:00 PM
Sheraton Times Square
Room: Central Park
Description
Objective:
Deep hypothermic circulatory arrest (DHCA) in patients undergoing descending (DTA) or thoracoabdominal aortic aneurysm (TAAA) repair is associated with increased morbidity, particularly pulmonary complications, and mortality. We present our outcomes after open DTA and TAAA repair with and without DHCA.
Methods:
We performed a retrospective review of a prospectively maintained aortic database. From 1998 to 2022, 267 patients underwent open DTA or TAAA repair by a single surgeon. Of these, 81 (30.3%) patients required DHCA because proximal cross-clamping was not feasible or aneurysmal pathology extended into the arch. The other 135 (50.6%) patients required either atrial-femoral bypass or femoral-femoral bypass. Of those that used atrial-femoral bypass, 30 (41.7%) patients had DTA repair and 42 (58.3%) patients had TAAA repair. Of those that used femoral-femoral bypass, 21 (31.3%) patients had DTA repair and 46 (68.6%) patients had TAAA repair. There were 59 (72.8%) DHCA patients and 86 (63.7%) non-DHCA patients with DTA or Crawford extent I TAAAs. The 51 (19.1%) patients who underwent surgery with the clamp-and-sew technique were excluded. Because of intrinsic pathological differences in patients requiring DHCA, confidence intervals were used to compare groups in lieu of p-values.
Results:
DHCA patients had more chronic dissections (64.2% vs 42.2%, 95% CI for difference: 0.08 - 0.36) and higher BMIs (29.5 ± 6.8 vs 27.3 ± 6.7, CI: 0.12 - 4.07). More non-DHCA patients had medial degeneration (9.9% vs 31.1%, CI: -0.33 - -0.07) and diabetes (11% vs 23%, CI: -0.23 - -0.01). There were 10 (12.4%) in-hospital deaths for the DHCA and 10 (7.4%) for the non-DHCA group (CI: -0.04 - 0.14). There were 4 (4.9%) in the DHCA and 5 (3.7%) in the non-DHCA group that developed stroke (CI: -0.05 - 0.08). Two (2.5%) patients in the DHCA group and two (1.5%) patients in the non-DHCA group developed permanent paraplegia (CI: -0.04 - 0.06). Three (3.7%) in the DHCA and nine (6.7%) in the non-DHCA group developed renal failure requiring dialysis (CI: -0.10 - 0.04). There were no differences in the incidence of pulmonary complications, particularly prolonged ventilation (>48 hours) (46.3% vs 36.3%, CI: -0.04 - 0.25), pneumonia (17.3% vs 12.9%, CI: -0.05 - 0.16), or tracheostomy (12.4% vs 13.3%, CI: -0.11 - 0.09) between DHCA and non-DHCA, respectively. The only meaningful differences in postoperative outcomes were ICU (5.5 (IQR: 3-19.75) days vs 6 (IQR: 4-10) days, CI: 0.43-9.0) and hospital length of stays (19 (IQR: 11-29) days vs 12 (IQR: 10-19) days, CI: 2.4-14.2), which were both longer in the DHCA group (Table 1).
Conclusions:
Despite longer ICU and hospital length of stays, DHCA is safe and effective with comparable morbidity and mortality to non-DHCA in open DTA and TAAA repair.
Authors
joshua chen (1), Vishal Shah (1), Scott Koeneman (2), Jacqueline McGee (1), Megary McCoy (1), Colin King (1), Jeffrey Zucker (1), Konstadinos Plestis (1)
Institutions
(1) Thomas Jefferson University Hospital, Philadelphia, PA, (2) Sidney Kimmel Medical College, Division of Biostatistics, Philadelphia, PA
Deep hypothermic circulatory arrest (DHCA) in patients undergoing descending (DTA) or thoracoabdominal aortic aneurysm (TAAA) repair is associated with increased morbidity, particularly pulmonary complications, and mortality. We present our outcomes after open DTA and TAAA repair with and without DHCA.
Methods:
We performed a retrospective review of a prospectively maintained aortic database. From 1998 to 2022, 267 patients underwent open DTA or TAAA repair by a single surgeon. Of these, 81 (30.3%) patients required DHCA because proximal cross-clamping was not feasible or aneurysmal pathology extended into the arch. The other 135 (50.6%) patients required either atrial-femoral bypass or femoral-femoral bypass. Of those that used atrial-femoral bypass, 30 (41.7%) patients had DTA repair and 42 (58.3%) patients had TAAA repair. Of those that used femoral-femoral bypass, 21 (31.3%) patients had DTA repair and 46 (68.6%) patients had TAAA repair. There were 59 (72.8%) DHCA patients and 86 (63.7%) non-DHCA patients with DTA or Crawford extent I TAAAs. The 51 (19.1%) patients who underwent surgery with the clamp-and-sew technique were excluded. Because of intrinsic pathological differences in patients requiring DHCA, confidence intervals were used to compare groups in lieu of p-values.
Results:
DHCA patients had more chronic dissections (64.2% vs 42.2%, 95% CI for difference: 0.08 - 0.36) and higher BMIs (29.5 ± 6.8 vs 27.3 ± 6.7, CI: 0.12 - 4.07). More non-DHCA patients had medial degeneration (9.9% vs 31.1%, CI: -0.33 - -0.07) and diabetes (11% vs 23%, CI: -0.23 - -0.01). There were 10 (12.4%) in-hospital deaths for the DHCA and 10 (7.4%) for the non-DHCA group (CI: -0.04 - 0.14). There were 4 (4.9%) in the DHCA and 5 (3.7%) in the non-DHCA group that developed stroke (CI: -0.05 - 0.08). Two (2.5%) patients in the DHCA group and two (1.5%) patients in the non-DHCA group developed permanent paraplegia (CI: -0.04 - 0.06). Three (3.7%) in the DHCA and nine (6.7%) in the non-DHCA group developed renal failure requiring dialysis (CI: -0.10 - 0.04). There were no differences in the incidence of pulmonary complications, particularly prolonged ventilation (>48 hours) (46.3% vs 36.3%, CI: -0.04 - 0.25), pneumonia (17.3% vs 12.9%, CI: -0.05 - 0.16), or tracheostomy (12.4% vs 13.3%, CI: -0.11 - 0.09) between DHCA and non-DHCA, respectively. The only meaningful differences in postoperative outcomes were ICU (5.5 (IQR: 3-19.75) days vs 6 (IQR: 4-10) days, CI: 0.43-9.0) and hospital length of stays (19 (IQR: 11-29) days vs 12 (IQR: 10-19) days, CI: 2.4-14.2), which were both longer in the DHCA group (Table 1).
Conclusions:
Despite longer ICU and hospital length of stays, DHCA is safe and effective with comparable morbidity and mortality to non-DHCA in open DTA and TAAA repair.
Authors
joshua chen (1), Vishal Shah (1), Scott Koeneman (2), Jacqueline McGee (1), Megary McCoy (1), Colin King (1), Jeffrey Zucker (1), Konstadinos Plestis (1)
Institutions
(1) Thomas Jefferson University Hospital, Philadelphia, PA, (2) Sidney Kimmel Medical College, Division of Biostatistics, Philadelphia, PA
Presentation Duration
PODS will be on display in the exhibit hall for the duration of the meeting during exhibit hall hours. PODS will also be available for viewing on the meeting website. There is no formal presentation associated with your POD, but we encourage you to visit the PODS area during breaks to connect with those viewing.